als treatment

20 maj 2025 — The only available drug, riluzol (Rilutek), was manufactured in the 1990s and it slows the disease progression somewhat. Clinical studies have ...

Medications. The Food and Drug Administration has approved two medicines for treating ALS : Riluzole (Rilutek, Exservan, Tiglutik). Taken by mouth, this ...

26 apr. 2024 — The promising results seen in patients with SOD1 ALS disease has inspired the ATLAS-study, where early treatment with tofersen in healthy ...

26 mars 2025 — A treatment plan for ALS usually includes rehabilitation, which should be tailored to the person's individual needs. It may include physical, ...

22 dec. 2025 — Long-term use of tofersen slows ALS disease progression in people with a genetic subtype, provides hope for treating other forms of ALS.

Rilutek (now generic) was the first FDA-approved drug to treat ALS. It is taken as a tablet. A thickened liquid form of riluzole called Tiglutik was approved by ...

25 juni 2025 — The hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past decade, with six drugs approved by American regulators.

FDA-approved treatments that slow the progression of ALS include riluzole and edaravone. Non-invasive ventilation may result in ...

30 dec. 2025 — Researchers have announced evidence that early, sustained treatment can meaningfully slow the disease and extend survival in a rare genetic form ...